SuperworthMedifast EPS MED
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$2.33
- Latest quarter, Q2 FY26
- −$0.28
- −227% on a year earlier
- Fiscal year 2025
- −$1.71
- −1050% on the year before
Medifast's earnings per share was −$2.33 over the twelve months to Jun 30, 2026, down 828% on a year earlier.
In its latest quarter, Q2 FY26, it was −$0.28, down 227% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.71 | −1050% |
| FY2024 | $0.18 | −98% |
| FY2023 | $9.11 | −28% |
| FY2022 | $12.69 | −9% |
| FY2021 | $13.88 | +60% |
| FY2020 | $8.69 | +35% |
| FY2019 | $6.43 | +39% |
| FY2018 | $4.61 | +101% |
| FY2017 | $2.29 | +53% |
| FY2016 | $1.50 | −9% |
| FY2015 | $1.65 | +65% |
| FY2014 | $1.00 | −43% |
| FY2013 | $1.74 | +51% |
| FY2012 | $1.15 | −11% |
| FY2011 | $1.29 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.28 | −227% | −$2.33 | |
| Q1 FY26 | −$0.19 | n/a | −$1.83 | |
| Q4 FY25 | −$1.65 | −2457% | −$1.71 | |
| Q3 FY25 | −$0.21 | −310% | $0.01 | |
| Q2 FY25 | $0.22 | n/a | $0.32 | |
| Q1 FY25 | −$0.07 | −109% | −$0.65 | |
| Q4 FY24 | $0.07 | −87% | $0.18 | |
| Q3 FY24 | $0.10 | −95% | $0.66 | |
| Q2 FY24 | −$0.75 | −127% | $2.68 | |
| Q1 FY24 | $0.76 | −79% | $6.20 | |
| Q4 FY23 | $0.55 | −77% | $9.11 | |
| Q3 FY23 | $2.12 | −35% | $10.97 |
Against its peers
Companies in Packaged Foods nearest Medifast's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MEDMedifast | −$2.33 | −828% a year |
| LWAYLifeway Foods | $0.70 | +1% a year |
| MAMAMama's Creations | $0.17 | +55% a year |
| JVACoffee | $0.83 | +159% a year |
| SENEASeneca Foods | $17.32 | +178% a year |
| BRBRBellring Brands | $1.42 | −19% a year |
| FLOFlowers Foods | $0.26 | −75% a year |
| Peer median | $0.77 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Medifast
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.